Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

ABSTRACTOncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic onco...